Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The raise will go toward trialing the company’s lead drug for phosphomannomutase-2 congenital disorder of glycosylation, a ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

Effective treatments for ARVC are lacking. Whereas mRNA-based therapies have shown efficacy in humans, their therapeutic potential for inherited cardiomyopathies remains unclear. A novel insertion ...

Market OverviewThe Global Nanomedicine Market is valued at USD 273.79 Billion in 2024 and is projected to reach a value of ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and collaborators ...

Ethris and Lonza collaborate to develop spray-dried mRNA vaccines for respiratory disease prevention: Munich, Germany Wednesday, April 9, 2025, 13:00 Hrs [IST] Ethris, a clinical- ...

Ionizable lipids are essential components of lipid nanoparticles (LNPs) for efficient mRNA delivery, however, efficiently optimizing their chemical structures remains challenging. Here ...

The global lipid nanoparticles market, valued at US$ 820.51 million in 2023, is projected to experience significant growth, with an expected market valuation of US$ 2,387.98 million by 2032. This ...